首页|Polymorphism in the Hsa-miR-4274 seed region influences the expression of PEX5 and enhances radiotherapy resistance in colorectal cancer
Polymorphism in the Hsa-miR-4274 seed region influences the expression of PEX5 and enhances radiotherapy resistance in colorectal cancer
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
万方数据
维普
Polymorphism in the Hsa-miR-4274 seed region influences the expression of PEX5 and enhances radiotherapy resistance in colorectal cancer
Identifying biomarkers for predicting radiotherapy efficacy is crucial for optimizing personalized treatments.We previously reported that rs1553867776 in the miR-4274 seed region can predict survival in patients with rectal cancer receiving postoperative chemoradiation therapy.Hence,to investigate the molecular mechanism of the genetic variation and its impact on the radiosensitivity of colorectal cancer(CRC),in this study,bioinformatics analysis is combined with functional experiments to confirm peroxisomal biogenesis factor 5(PEX5)as a direct target of miR-4274.The miR-4274 rs1553867776 variant influences the binding of miR-4274 and PEX5 mRNA,which subsequently regulates PEX5 protein expression.The interaction between PEX5 and Ku70 was verified by co-immunoprecipitation and immunofluorescence.A xenograft tumor model was established to validate the effects of miR-4274 and PEX5 on CRC progression and radiosensitivity in vivo.The overexpression of PEX5 enhances radiosensitivity by preventing Ku70 from entering the nucleus and reducing the repair of ionizing radiation(IR)-induced DNA damage by the Ku70/Ku80 complex in the nucleus.In addition,the enhanced expression of PEX5 is associated with increased IR-induced ferroptosis.Thus,targeting this mechanism might effectively increase the radiosensitivity of CRC.These findings offer novel insights into the mechanism of cancer radioresistance and have important implications for clinical radiotherapy.
Qixuan Lu、Ningxin Ren、Hongxia Chen、Shaosen Zhang、Ruoqing Yan、Mengjie Li、Linlin Zheng、Wen Tan、Dongxin Lin
展开 >
State Key Laboratory of Molecular Oncology,Department of Etiology and Carcinogenesis,Beijing Key Laboratory for Carcinogenesis and Cancer Prevention,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China
Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China,Guangzhou 510060,China
colorectal cancer polymorphism miR-4274 PEX5 radiotherapy resistance
万方数据
维普
